Refine
Year of publication
Language
- English (32)
Has Fulltext
- yes (32)
Is part of the Bibliography
- no (32)
Keywords
- extracellular matrix (5)
- Decorin (4)
- autophagy (4)
- cancer (4)
- inflammation (4)
- fibrosis (3)
- proteoglycan (3)
- Biglycan (2)
- IR-A (2)
- Proliferation (2)
- Signaling (2)
- Toll-like receptor (2)
- angiogenesis (2)
- macrophage (2)
- A498 cells (1)
- ACLF (1)
- ADAM10 (1)
- ATP (1)
- Autophagy (1)
- Bacterial infection (1)
- Bacterial pathogenesis (1)
- CTGF (1)
- CXCL16 (1)
- Cell surface proteoglycans (1)
- Collagen (1)
- Duchenne’s muscular dystrophy (1)
- ErbB-signaling (1)
- Extracellular matrix (1)
- Fibrosis (1)
- GLI inhibitors (1)
- Heat Shock Protein (HSP) (1)
- Heparan Sulfate (1)
- Hepatic stellate cell (1)
- Hyaluronan (1)
- Inflammasome (1)
- Inflammation (1)
- Innate immunity (1)
- Liver fibrosis (1)
- Lumican (1)
- Metalloproteinases (1)
- NASH (1)
- Necrosis (Necrotic Death) (1)
- Peg3 (1)
- Progranulin (1)
- RCC (1)
- S1P (1)
- S1P receptors (1)
- S1P5 (1)
- S1PR5 (1)
- SARS-CoV-2 (1)
- Small Leucine-rich Proteoglycan (SLRP) (1)
- TGF-α (1)
- TGF-β (1)
- TGF-β1 (1)
- TGFβ (1)
- Toll-like Receptor (TLR) (1)
- Wnt (1)
- aging (1)
- amphiregulin (1)
- angiostasis (1)
- bacterial translocation (1)
- biglycan (1)
- bone (1)
- cancer stem cells (1)
- chemoattractant (1)
- chronic kidney disease (1)
- damage-associated molecular pattern (1)
- decorin (1)
- diabetic nephropathy (1)
- enolase-1 (1)
- epidermal growth factor (1)
- epidermal growth factor receptor (1)
- fibromodulin (1)
- glioma-associated oncogene homolog (1)
- glycolysis (1)
- glycosaminoglycan (1)
- hedgehog signaling (1)
- hypothalamus (1)
- idiopathic pulmonary fibrosis (1)
- inflammasome (1)
- knockout mice (1)
- lipid signaling (1)
- lumican (1)
- lung fibrosis (1)
- lysophospholipids (1)
- mitophagy (1)
- mitostatin (1)
- multitasking protein (1)
- nephropathy (1)
- neuregulin 1 (1)
- neurodegenerative diseases (1)
- podocytes (1)
- polydipsia (1)
- polyuria (1)
- primary tubular cells (1)
- protein compartmentalization (1)
- proteoglycans (1)
- pulmonary fibrosis (1)
- renal inflammation (1)
- sepsis (1)
- skeletal muscle (1)
- small leucine-rich proteoglycan (1)
- small leucine-rich proteoglycans (1)
- sphingolipid (1)
- sphingolipids (1)
- sphingosine 1-phosphate homologues (1)
- toll-like receptor (1)
- toll-like receptors (1)
- transforming growth factor beta (1)
- tyrosine kinase inhibitor (1)
- vasopressin (1)
Autophagy plays an essential role in maintaining an intricate balance between nutrient demands and energetic requirements during normal homeostasis. Autophagy recycles metabolic substrates from nonspecific bulk degradation of proteins and excess or damaged organelles. Recent work posits an active and dynamic signaling role for extracellular matrix-evoked autophagic regulation, that is, allosteric and independent of prevailing nutrient conditions. Several candidates, representing a diverse repertoire of matrix constituents (decorin, collagen VI, laminin α2, endostatin, endorepellin, and kringle V), can modulate autophagic signaling pathways. Importantly, a novel principle indicates that matrix constituents can differentially modulate autophagic induction and repression via interaction with specific receptors. Most of the matrix-derived factors described here appear to control autophagy in a canonical manner but independent of nutrient deprivation. Because the molecular composition and structure of the extracellular matrix are dynamically remodeled during various physiological and pathological conditions, we propose that matrix-regulated autophagy is key for maintaining proper tissue homeostasis and disease prevention, such as cancer progression and muscular dystrophies.
Sphingosine 1-phosphate (S1P) is a lipid mediator with numerous biological functions. The term ‘S1P’ mainly refers to the sphingolipid molecule with a long-chain sphingoid base of 18 carbon atoms, d18:1 S1P. The enzyme serine palmitoyltransferase catalyses the first step of the sphingolipid de novo synthesis using palmitoyl-CoA as the main substrate. After further reaction steps, d18:1 S1P is generated. However, also stearyl-CoA or myristoyl-CoA can be utilised by the serine palmitoyltransferase, which at the end of the S1P synthesis pathway, results in the production of d20:1 S1P and d16:1 S1P respectively. We measured these S1P homologues in mice and renal tissue of patients suffering from renal cell carcinoma (RCC). Our experiments highlight the relevance of d16:1 S1P for the induction of connective tissue growth factor (CTGF) in the human renal clear cell carcinoma cell line A498 and human RCC tissue. We show that d16:1 S1P versus d18:1 and d20:1 S1P leads to the highest CTGF induction in A498 cells via S1P2 signalling and that both d16:1 S1P and CTGF levels are elevated in RCC compared to adjacent healthy tissue. Our data indicate that d16:1 S1P modulates conventional S1P signalling by acting as a more potent agonist at the S1P2 receptor than d18:1 S1P. We suggest that elevated plasma levels of d16:1 S1P might play a pro-carcinogenic role in the development of RCC via CTGF induction.